| Year |
Citation |
Score |
| 2020 |
Brice J, Sylla M, Desire N, Sayon S, Telly F, Bocar-Fofana D, Murphy R, Peytavin G, Diallo S, Nastouli E, Calvez V, Marcelin AG, Issiaka Maiga A, Lambert-Niclot S. Characterization of drug resistance and the defective HIV reservoir in virally suppressed vertically infected children in Mali. The Journal of Antimicrobial Chemotherapy. PMID 32073629 DOI: 10.1093/Jac/Dkaa002 |
0.357 |
|
| 2020 |
Adeola J, Badejo OA, Ahonkhai A, Okonkwo P, Aboh Akande P, Evans CT, McHugh M, Pierce L, Ahmed I, Jolayemi T, Ladi Akinyemi B, Onwuatuelo I, Murphy R, Kyriacou D, Musa J, et al. Effect of Baseline Symptom Manifestations on Retention in Care and Treatment among HIV-Infected Patients in Nigeria. Journal of the International Association of Providers of Aids Care. 19: 2325958220903575. PMID 32027211 DOI: 10.1177/2325958220903575 |
0.361 |
|
| 2019 |
Jary A, Dienta S, Leducq V, Le Hingrat Q, Cisse M, Diarra AB, Fofana DB, Ba A, Baby M, Achenbach CJ, Murphy R, Calvez V, Marcelin AG, Maiga AI. Seroprevalence and risk factors for HIV, HCV, HBV and syphilis among blood donors in Mali. Bmc Infectious Diseases. 19: 1064. PMID 31856758 DOI: 10.1186/S12879-019-4699-3 |
0.329 |
|
| 2019 |
Grant JL, Agaba P, Ugoagwu P, Muazu A, Okpokwu J, Akpa S, Machenry S, Imade G, Agbaji O, Thio CL, Murphy R, Hawkins C. Changes in liver stiffness after ART initiation in HIV-infected Nigerian adults with and without chronic HBV. The Journal of Antimicrobial Chemotherapy. 74: 2003-2008. PMID 31225612 DOI: 10.1093/Jac/Dkz145 |
0.367 |
|
| 2019 |
Christian B, Fabian E, Macha I, Mpangala S, Thio CL, Ulenga N, Mugusi F, Ammerman LR, Fawzi W, Green R, Murphy R, Hawkins C. Hepatitis B virus coinfection is associated with high early mortality in HIV-infected Tanzanians on antiretroviral therapy. Aids (London, England). 33: 465-473. PMID 30702515 DOI: 10.1097/Qad.0000000000002073 |
0.378 |
|
| 2018 |
Togo J, Maiga AI, Sylla M, Kone B, Dolo O, Traore FT, Sangare SA, Maiga M, Diallo S, Murphy R, Calvez V, Marcelin AG. Evaluation of Two HIV Rapid Diagnostic Tests in a Context of Strains' Genetic Diversity in Mali. Aids Research and Human Retroviruses. PMID 30560678 DOI: 10.1089/Aid.2017.0296 |
0.355 |
|
| 2018 |
Robertson KR, Jiang H, Kumwenda J, Supparatpinyo K, Marra CM, Berzins B, Hakim J, Sacktor N, Campbell TB, Schouten J, Mollan K, Tripathy S, Kumarasamy N, La Rosa A, Santos B, ... ... Murphy R, et al. HIV Associated Neurocognitive Impairment in Diverse Resource Limited Settings. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 30219843 DOI: 10.1093/Cid/Ciy767 |
0.386 |
|
| 2017 |
Hawkins C, Christian B, Fabian E, Macha I, Gawile C, Mpangala S, Ulenga N, Thio CL, Ammerman LR, Mugusi F, Fawzi W, Green R, Murphy R. Brief Report: HIV/HBV Coinfection is a Significant Risk Factor for Liver Fibrosis in Tanzanian HIV-Infected Adults. Journal of Acquired Immune Deficiency Syndromes (1999). 76: 298-302. PMID 29016448 DOI: 10.1097/Qai.0000000000001491 |
0.37 |
|
| 2017 |
Steens JM, Scherrer D, Gineste P, Barrett PN, Kuanchai S, Winai R, Ruxrungtham K, Tazi J, Murphy R, Ehrlich H. Safety, Pharmacokinetics and_Antiviral Activity of a Novel HIV Antiviral, ABX464, in Treatment- Naïve HIV Infected Subjects: a Phase II Randomized, Controlled Study. Antimicrobial Agents and Chemotherapy. PMID 28507108 DOI: 10.1128/Aac.00545-17 |
0.384 |
|
| 2017 |
Grant J, Agbaji O, Kramvis A, Yousif M, Auwal M, Penugonda S, Ugoagwu P, Murphy R, Hawkins C. Hepatitis B Virus Sequencing and Liver Fibrosis Evaluation in HIV/HBV Co-infected Nigerians. Tropical Medicine & International Health : Tm & Ih. PMID 28376292 DOI: 10.1111/Tmi.12873 |
0.316 |
|
| 2016 |
Brice J, Sylla M, Sayon S, Telly F, Bocar-Fofana D, Murphy R, Lambert-Niclot S, Todesco E, Grude M, Barin F, Diallo S, Pillay D, Derache A, Calvez V, Marcelin AG, et al. Qualitative and quantitative HIV antibodies and viral reservoir size characterization in vertically infected children with virological suppression. The Journal of Antimicrobial Chemotherapy. PMID 28039275 DOI: 10.1093/Jac/Dkw537 |
0.361 |
|
| 2016 |
Scherrer D, Steens J, Kuanchai S, Winai R, Ruxrungtham K, Rouzier R, Tazi J, Gineste P, Ehrlich H, Murphy R. P3 Early evidence of antiviral activity and safety of ABX464 in HIV treatment-naïve patients Journal of Virus Eradication. 2: 4-5. DOI: 10.1016/S2055-6640(20)31090-6 |
0.38 |
|
| 2013 |
Brown TT, Chen Y, Currier JS, Ribaudo HJ, Rothenberg J, Dubé MP, Murphy R, Stein JH, McComsey GA. Body composition, soluble markers of inflammation, and bone mineral density in antiretroviral therapy-naive HIV-1-infected individuals. Journal of Acquired Immune Deficiency Syndromes (1999). 63: 323-30. PMID 23591634 DOI: 10.1097/Qai.0B013E318295Eb1D |
0.357 |
|
| 2013 |
Agbaji O, Thio CL, Meloni S, Graham C, Muazu M, Nimzing L, Idoko J, Sankalé JL, Ekong E, Murphy R, Kanki P, Hawkins C. Impact of hepatitis C virus on HIV response to antiretroviral therapy in Nigeria. Journal of Acquired Immune Deficiency Syndromes (1999). 62: 204-7. PMID 23196830 DOI: 10.1097/Qai.0B013E31827Ce536 |
0.362 |
|
| 2013 |
Adetunji AA, Achenbach C, Feinglass J, Darin KM, Scarsi KK, Ekong E, Taiwo BO, Adewole IF, Murphy R. Optimizing treatment switch for virologic failure during first-line antiretroviral therapy in resource-limited settings. Journal of the International Association of Providers of Aids Care. 12: 236-40. PMID 23128403 DOI: 10.1177/1545109712463733 |
0.325 |
|
| 2013 |
Ghosn J, Slama L, Chermak A, Houssaini A, Lambert-Niclot S, Schneider L, Fourn E, Duvivier C, Simon A, Courbon E, Murphy R, Flandre P, Peytavin G, Katlama C. Switching to darunavir/ritonavir 800/100 mg once-daily containing regimen maintains virological control in fully suppressed pre-treated patients infected with HIV-1. Journal of Medical Virology. 85: 8-15. PMID 23024008 DOI: 10.1002/Jmv.23404 |
0.385 |
|
| 2013 |
Maiga AI, Fofana DB, Maiga AC, Diallo F, Ait-Arkoub Z, Daou F, Cisse M, Sarro YDS, Oumar AA, Sylla A, Katlama C, Taiwo B, Murphy R, Tounkara A, Marcelin AG, et al. Transmitted antiretroviral drug resistance in newly HIV-Infected and untreated patients in ségou and bamako, mali Aids Research and Human Retroviruses. 29: 182-186. PMID 22823755 DOI: 10.1089/Aid.2012.0118 |
0.394 |
|
| 2012 |
Maiga AI, Fofana DB, Cisse M, Diallo F, Maiga MY, Traore HA, Maiga IA, Sylla A, Fofana D, Taiwo B, Murphy R, Katlama C, Tounkara A, Calvez V, Marcelin AG. Characterization of HIV-1 antiretroviral drug resistance after second-line treatment failure in Mali, a limited-resources setting Journal of Antimicrobial Chemotherapy. 67: 2943-2948. PMID 22888273 DOI: 10.1093/Jac/Dks310 |
0.377 |
|
| 2012 |
Robertson K, Jiang H, Kumwenda J, Supparatpinyo K, Evans S, Campbell TB, Price R, Tripathy S, Kumarasamy N, La Rosa A, Santos B, Silva MT, Montano S, Kanyama C, ... ... Murphy R, et al. Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: AIDS Clinical Trials Group study a5199, the International Neurological Study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 55: 868-76. PMID 22661489 DOI: 10.1093/Cid/Cis507 |
0.345 |
|
| 2012 |
Manion M, Rodriguez B, Medvik K, Hardy G, Harding CV, Schooley RT, Pollard R, Asmuth D, Murphy R, Barker E, Brady KE, Landay A, Funderburg N, Sieg SF, Lederman MM. Interferon-alpha administration enhances CD8+ T cell activation in HIV infection. Plos One. 7: e30306. PMID 22291932 DOI: 10.1371/Journal.Pone.0030306 |
0.349 |
|
| 2012 |
Agaba P, Sule H, Ojoh R, Saidu Z, Mua’zu M, Agbaji O, Idoko J, Ekong E, Murphy R, Kanki P. Poor immune status and systemic disease are independently associated with mortality in AIDS-related Kaposi Sarcoma in Nigeria Infectious Agents and Cancer. 7. DOI: 10.1186/1750-9378-7-S1-P7 |
0.327 |
|
| 2011 |
Robertson K, Kumwenda J, Supparatpinyo K, Jiang JH, Evans S, Campbell TB, Price RW, Murphy R, Hall C, Marra CM, Marcus C, Berzins B, Masih R, Santos B, Silva MT, et al. A multinational study of neurological performance in antiretroviral therapy-naïve HIV-1-infected persons in diverse resource-constrained settings. Journal of Neurovirology. 17: 438-47. PMID 21786076 DOI: 10.1007/S13365-011-0044-3 |
0.4 |
|
| 2011 |
Agaba PA, Digin E, Makai R, Apena L, Agbaji OO, Idoko JA, Murphy R, Kanki P. Clinical characteristics and predictors of mortality in hospitalized HIV-infected Nigerians. Journal of Infection in Developing Countries. 5: 377-82. PMID 21628815 DOI: 10.3855/Jidc.1096 |
0.371 |
|
| 2011 |
Otegbayo JA, Akingbola TS, Akinyemi JO, Adedapo KS, Odaibo GN, Óva YAA, Olaleye DO, Adewole IF, Murphy R, Kanki P. Immunovirological and Biochemical Changes in Nigerian Patients with Hepatitis B Coinfection on Antiretroviral Therapy World Journal of Aids. 1: 31-36. DOI: 10.4236/Wja.2011.12006 |
0.425 |
|
| 2010 |
Dominguez S, Ghosn J, Peytavin G, Guiguet M, Tubiana R, Valantin MA, Murphy R, Bricaire F, Benhamou Y, Katlama C. Impact of hepatitis C and liver fibrosis on antiretroviral plasma drug concentrations in HIV-HCV co-infected patients: The HEPADOSE study Journal of Antimicrobial Chemotherapy. 65: 2445-2449. PMID 20813809 DOI: 10.1093/Jac/Dkq320 |
0.389 |
|
| 2010 |
Taiwo B, Chaplin B, Penugonda S, Meloni S, Akanmu S, Gashau W, Idoko J, Adewole I, Murphy R, Kanki P. Suboptimal etravirine activity is common during failure of nevirapine-based combination antiretroviral therapy in a cohort infected with non-B subtype HIV-1. Current Hiv Research. 8: 194-8. PMID 20163340 DOI: 10.2174/157016210791111098 |
0.388 |
|
| 2009 |
Idoko J, Meloni S, Muazu M, Nimzing L, Badung B, Hawkins C, Sankalé JL, Ekong E, Murphy R, Kanki P, Thio CL. Impact of hepatitis B virus infection on human immunodeficiency virus response to antiretroviral therapy in Nigeria. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 49: 1268-73. PMID 19772386 DOI: 10.1086/605675 |
0.303 |
|
| 2009 |
Katlama C, Murphy R. Emerging role of integrase inhibitors in the management of treatment-experienced patients with HIV infection. Therapeutics and Clinical Risk Management. 5: 331-340. PMID 19536321 DOI: 10.2147/Tcrm.S3137 |
0.411 |
|
| 2009 |
Soulié C, Tubiana R, Simon A, Lambert-Niclot S, Malet I, Canestri A, Brunet C, Murphy R, Katlama C, Calvez V, Marcelin AG. Presence of HIV-1 R5 viruses in cerebrospinal fluid even in patients harboring R5X4/X4 viruses in plasma. Journal of Acquired Immune Deficiency Syndromes. 51: 60-64. PMID 19390328 DOI: 10.1097/Qai.0B013E31819Fb903 |
0.346 |
|
| 2009 |
Tebas P, Zhang J, Hafner R, Tashima K, Shevitz A, Yarasheski K, Berzins B, Owens S, Forand J, Evans S, Murphy R. Peripheral and visceral fat changes following a treatment switch to a non-thymidine analogue or a nucleoside-sparing regimen in HIV-infected subjects with peripheral lipoatrophy: results of ACTG A5110. The Journal of Antimicrobial Chemotherapy. 63: 998-1005. PMID 19299471 DOI: 10.1093/Jac/Dkp071 |
0.33 |
|
| 2008 |
Calmy A, Pizzocolo C, Pizarro L, Brücker G, Murphy R, Katlama C, Autran B, Balkan S, Bonnet F, Bradol JH, Calvez V, Carcelain G, Clumeck N, Dabis F, Delaporte E, et al. The marriage of science and optimized HIV care in resource-limited settings Aids. 22: 2227-2230. PMID 18981761 DOI: 10.1097/Qad.0B013E32830F4C4D |
0.364 |
|
| 2008 |
Amellal B, Murphy R, Maiga A, Brucker G, Katlama C, Calvez V, Marcelin AG. Stability of HIV RNA in plasma specimens stored at different temperatures Hiv Medicine. 9: 790-793. PMID 18754803 DOI: 10.1111/J.1468-1293.2008.00632.X |
0.339 |
|
| 2008 |
Ojesina AI, Chaplin B, Sankalé JL, Murphy R, Idigbe E, Adewole I, Ekong E, Idoko J, Kanki PJ. Interplay of reverse transcriptase inhibitor therapy and gag p6 diversity in HIV type 1 subtype G and CRF02_AG. Aids Research and Human Retroviruses. 24: 1167-74. PMID 18729771 DOI: 10.1089/Aid.2007.0308 |
0.335 |
|
| 2008 |
Murphy R, Costagliola D. Increased cardiovascular risk in HIV infection: drugs, virus and immunity. Aids. 22: 1625-1627. PMID 18670222 DOI: 10.1097/Qad.0B013E328306A6Db |
0.4 |
|
| 2008 |
Ait-Mohand H, Bonmarchand M, Guiguet M, Slama L, Marguet F, Behin A, Amellal B, Bennai Y, Peytavin G, Calvez V, Pialoux G, Murphy R, Katlama C. Viral efficacy maintained and safety parameters improved with a reduced dose of stavudine: a pilot study. Hiv Medicine. 9: 738-746. PMID 18651858 DOI: 10.1111/J.1468-1293.2008.00616.X |
0.325 |
|
| 2007 |
Rachlis A, Clotet B, Baxter J, Murphy R, Lefebvre E. Safety, tolerability, and efficacy of darunavir (TMC114) with low-dose ritonavir in treatment-experienced, hepatitis B or C co-infected patients in POWER 1 and 3. Hiv Clinical Trials. 8: 213-220. PMID 17720661 DOI: 10.1310/Hct0804-213 |
0.344 |
|
| 2007 |
Taiwo BO, Murphy R. Transmitted Resistance: An Overview and Its Potential Relevance to the Management of HIV-Infected Persons in Resource-Limited Settings. Journal of the International Association of Physicians in Aids Care (Jiapac). 6: 188-197. PMID 17473177 DOI: 10.1177/1545109707300683 |
0.307 |
|
| 2006 |
Taiwo B, Murphy R. Outcomes for therapeutic vaccines trials. Current Opinion in Hiv and Aids. 1: 502-506. PMID 19372853 DOI: 10.1097/01.Coh.0000250321.50408.0A |
0.33 |
|
| 2004 |
Autran B, Costagliola D, Murphy R, Katlama C. Evaluating therapeutic vaccines in patients infected with HIV. Expert Review of Vaccines. 3. PMID 15285715 DOI: 10.1586/14760584.3.4.S169 |
0.408 |
|
| 2004 |
Wood R, Phanuphak P, Cahn P, Pokrovskiy V, Rozenbaum W, Pantaleo G, Sension M, Murphy R, Mancini M, Kelleher T, Giordano M. Long-term efficacy and safety of atazanavir with stavudine and lamivudine in patients previously treated with nelfinavir or atazanavir. Journal of Acquired Immune Deficiency Syndromes (1999). 36: 684-92. PMID 15167287 DOI: 10.1097/00126334-200406010-00005 |
0.377 |
|
| 2002 |
Davidson M, Min YI, Holbrook JT, Van Natta ML, Murphy R, Jabs DA, Welch W, Meinert CL. Use of filgrastim as adjuvant therapy in patients with AIDS-related cytomegalovirus retinitis. Aids (London, England). 16: 757-65. PMID 11964532 DOI: 10.1097/00002030-200203290-00011 |
0.305 |
|
| 2002 |
Falloon J, Ait-Khaled M, Thomas DA, Brosgart CL, Eron Jr JJ, Feinberg J, Flanigan TP, Hammer SM, Kraus PW, Murphy R, Torres R, Masur H. HIV-1 genotype and phenotype correlate with virological response to abacavir, amprenavir and efavirenz in treatment-experienced patients. Aids (London, England). 16: 387-96. PMID 11834950 DOI: 10.1097/00002030-200202150-00010 |
0.402 |
|
| 2001 |
Tebas P, Henry K, Nease R, Murphy R, Phair J, Powderly WG. Timing of antiretroviral therapy. Use of Markov modeling and decision analysis to evaluate the long-term implications of therapy Aids. 15: 591-599. PMID 11316996 DOI: 10.1097/00002030-200103300-00008 |
0.343 |
|
| 2001 |
Katzenstein DA, Hughes MD, Albrecht M, Liou SH, Murphy R, Balfour H, Para M, Hammer S. Virologic and CD4 cell response to zidovudine or zidovudine and lamivudine following didanosine treatment of human immunodeficiency virus infection. Aids Research and Human Retroviruses. 17: 203-10. PMID 11177402 DOI: 10.1089/088922201750063115 |
0.4 |
|
| 2000 |
Albrecht MA, Hughes MD, Liou SH, Katzenstein DA, Murphy R, Balfour HH, Para MF, Valdez H, Hammer SM. Effect of lamivudine in HIV-infected persons with prior exposure to zidovudine/didanosine or zidovudine/zalcitabine. Aids Research and Human Retroviruses. 16: 1337-44. PMID 11018853 DOI: 10.1089/08892220050140883 |
0.394 |
|
| 2000 |
Jabs DA, Freeman WR, Jacobson M, Murphy R, Van Natta ML, Meinert CL. Long-term follow-up of patients with AIDS treated with parenteral cidofovir for cytomegalovirus retinitis: The HPMPC peripheral cytomegalovirus retinitis trial. The studies of ocular complications of AIDS research group in collaboration with the AIDS clinical trials group Aids. 14: 1571-1581. PMID 10983644 DOI: 10.1097/00002030-200007280-00013 |
0.317 |
|
| 2000 |
Katzenstein DA, Hughes H, Albrecht M, Hammer S, Para M, Murphy R, Valdez H, Haubrich R, Liou S. Virologic and CD4+ Cell Responses to New Nucleoside Regimens: Switching to Stavudine or Adding Lamivudine after Prolonged Zidovudine Treatment of Human Immunodeficiency Virus Infection Aids Research and Human Retroviruses. 16: 1031-1037. PMID 10933617 DOI: 10.1089/08892220050075282 |
0.398 |
|
| 1999 |
Kahn J, Lagakos S, Wulfsohn M, Cherng D, Miller M, Cherrington J, Hardy D, Beall G, Cooper R, Murphy R, Basgoz N, Ng E, Deeks S, Winslow D, Toole JJ, et al. Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial. Jama. 282: 2305-12. PMID 10612317 DOI: 10.1001/Jama.282.24.2305 |
0.383 |
|
| 1998 |
Mueller BU, Anderson BD, Farley MQ, Murphy R, Zuckerman J, Jarosinski P, Godwin K, McCully CL, Mitsuya H, Pizzo PA, Balis FM. Pharmacokinetics of the protease inhibitor KNI-272 in plasma and cerebrospinal fluid in nonhuman primates after intravenous dosing and in human immunodeficiency virus-infected children after intravenous and oral dosing. Antimicrobial Agents and Chemotherapy. 42: 1815-8. PMID 9661027 DOI: 10.1128/Aac.42.7.1815 |
0.339 |
|
| 1997 |
Beal JE, Olson R, Lefkowitz L, Laubenstein L, Bellman P, Yangco B, Morales JO, Murphy R, Powderly W, Plasse TF, Mosdell KW, Shepard KV. Long-term efficacy and safety of dronabinol for acquired immunodeficiency syndrome-associated anorexia. Journal of Pain and Symptom Management. 14: 7-14. PMID 9223837 DOI: 10.1016/S0885-3924(97)00038-9 |
0.308 |
|
| 1997 |
Spruance SL, Pavia AT, Mellors JW, Murphy R, Gathe J, Stool E, Jemsek JG, Dellamonica P, Cross A, Dunkle L. Clinical efficacy of monotherapy with stavudine compared with zidovudine in HIV-infected, zidovudine-experienced patients. A randomized, double- blind, controlled trial Annals of Internal Medicine. 126: 355-363. PMID 9054279 DOI: 10.7326/0003-4819-126-5-199703010-00003 |
0.422 |
|
| 1996 |
Wallace MR, Moss RB, Beecham HJ, Grace CJ, Hersh EM, Peterson E, Murphy R, Shepp DH, Siegal FP, Turner JL, Safrin S, Carlo DJ, Levine AM. Early clinical markers and CD4 percentage in subjects with human immunodeficiency virus infection. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association. 12: 358-62. PMID 8673544 DOI: 10.1097/00042560-199608010-00005 |
0.372 |
|
| 1995 |
Park LP, Graham NMH, Jacobson LP, Murphy R, Besley D, Zucconi S, Muñoz A. Factors associated with changes in the use of antiretroviral therapy by a cohort of homosexual men infected with human immunodeficiency virus type 1 Clinical Infectious Diseases. 21: 930-937. PMID 8645842 DOI: 10.1093/Clinids/21.4.930 |
0.354 |
|
| 1995 |
Murphy R. Clinical aspects of human immunodeficiency virus disease: clinical rationale for treatment. The Journal of Infectious Diseases. 171. PMID 7861022 DOI: 10.1093/Infdis/171.Supplement_2.S81 |
0.347 |
|
| 1995 |
Havlir D, Cheeseman SH, Mclaughlin M, Murphy R, Erice A, Spector SA, Greenough TC, Sullivan JL, Hall D, Myers M, Lamson M, Richman DD. High-Dose Nevirapine: Safety, Pharmacokinetics, And Antiviral Effect In Patients With Human Immunodeficiency Virus Infection The Journal of Infectious Diseases. 171: 537-545. PMID 7533197 DOI: 10.1093/Infdis/171.3.537 |
0.318 |
|
| 1994 |
Weinberg DV, Murphy R, Naughton K. Combined daily therapy with intravenous ganciclovir and foscarnet for patients with recurrent cytomegalovirus retinitis. American Journal of Ophthalmology. 117: 776-82. PMID 8198162 DOI: 10.1016/S0002-9394(14)70322-8 |
0.302 |
|
| 1993 |
Wheat J, Hafner R, Wulfsohn M, Spencer P, Squires K, Powderly W, Wong B, Rinaldi M, Saag M, Hamill R, Murphy R, Connolly-Stringfield P, Briggs N, Owens S. Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome Annals of Internal Medicine. 118: 610-616. PMID 8383934 DOI: 10.7326/0003-4819-118-8-199304150-00006 |
0.301 |
|
| 1992 |
Hoover DR, Saah A, Bacellar H, Murphy R, Visscher B, Metz S, Anderson R, Kaslow RA. The progression of untreated HIV-1 infection prior to AIDS. American Journal of Public Health. 82: 1538-41. PMID 1359801 DOI: 10.2105/Ajph.82.11.1538 |
0.368 |
|
| 1991 |
Hoover DR, Graham NM, Bacellar H, Schrager LK, Kaslow R, Visscher B, Murphy R, Anderson R, Saah A. Epidemiologic patterns of upper respiratory illness and Pneumocystis carinii pneumonia in homosexual men. The American Review of Respiratory Disease. 144: 756-9. PMID 1928944 DOI: 10.1164/Ajrccm/144.4.756 |
0.342 |
|
| 1990 |
Landay A, Kessler HA, Benson CA, Pottage JC, Murphy R, Urbanski P, Kucik S, Phair J. Isolation of HIV-1 from monocytes of individuals negative by conventional culture. The Journal of Infectious Diseases. 161: 706-710. PMID 1969456 DOI: 10.1093/Infdis/161.4.706 |
0.345 |
|
| Show low-probability matches. |